Barclays PLC Timber Pharmaceuticals, Inc. Transaction History

Barclays PLC

  • $327 Billion
  • Q2 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 12, 2022
BUY
$0.24 - $0.39 $12,000 - $19,500
50,000 Added 93.28%
103,601 $33,000
Q1 2022

May 16, 2022
BUY
$0.28 - $0.41 $15,008 - $21,976
53,601 New
53,601 $21,000

About Timber Pharmaceuticals, Inc.

TMBR Quotes by TradingView
  • Ticker TMBR
  • Exchange NYSE
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 146,524,992
  • Description
  • Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company's lead product candidates include TMB-001, a patented topical formulation of isotretinoin that has completed Phase 2b clinical trial for the treatment of moderate to ...
More about TMBR
Track This Portfolio

Track Barclays PLC Portfolio

Follow Barclays PLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Barclays PLC, based on Form 13F filings with the SEC.

News

Stay updated on Barclays PLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email